(Q39752144)

14 September 2017

1 reference

title

Tumour microcirculation as a target for hyperthermia (English)

1 reference

14 September 2017

Reinhold HS

1

1 reference

14 September 2017

Endrich B

series ordinal

2

1 reference

14 September 2017

publication date

1 April 1986

1 reference

International Journal of Hyperthermia

14 September 2017

published in

1 reference

14 September 2017

volume

2

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

111-137

1 reference

Selective inhibition of microcirculation in tumor tissue

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Manipulated selective inhibition of microcirculation in cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Theoretical feasibility of vasodilator-enhanced local tumor heating.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Hyperthermia-induced vascular injury in normal and neoplastic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Circulatory responses of malignant tumors during hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

A survey of surface hemorheological experiments on the inhibition of fibrinogenin formation employing surface layers of fibrinogen systems with heparins and other substances. A contribution on antithrombogenic action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Temperature range and selective sensitivity of tumors to hyperthermia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Hyperthermia in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Influence of pH and thermotolerance on the enhancement of X-ray induced inactivation of cultured mammalian cells by hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Predictions of blood flow from thermal clearance during regional hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Canine normal and tumor tissue estimated blood flow during fractionated hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Vascular damage and delayed cell death in tumours after hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Metabolic changes during and after hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

pH distribution in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Circulatory and metabolic responses of malignant tumors during localized hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

The relevance of tumour pH to the treatment of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

Whole-body hyperthermia in cancer therapy: a report of a phase I–II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02656738609012389

10.3109/02656738609012389

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference